Tevogen Bio Holdings Inc.(TVGN)

Biotechnology · Warren, NJ

$6.52-0.08 (-1.21%)

Delayed quote: Oct 6, 2026, 2:32 PM EDT

Price/FCF Ratio: N/A

Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.

The Price/FCF ratio is N/A as of 2026-10-06T18:38:53.668Z.

Stored calculation inputs

Calculation as of: 2026-10-06T18:38:53.668Z.

Quote observation: 2026-10-06T18:32:54.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 27,150,617
TTM free cash flow · period ending 2026-06-30: -11,634,423

FMP input reference: 0d3a12511cd932522e29841d112ac79c3666bd2c66ede85cfa79360bad82955a

P/E Ratio|FCF Growth|Operating Margin|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

TVGN Price/FCF Ratio Metrics

PRICE/FCF RATIO

N/A

TVGN Competitors' Price/FCF Ratio

TVGN

Tevogen Bio Holdings Inc.

Current

Market Cap

$27.15M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MCRB

Seres Therapeutics, Inc.

vs TVGN

Market Cap

$27.79M

Price/FCF Ratio

N/A

TTM Avg

87.13

3Y Avg

87.13

5Y Avg

45.44

ATYR

aTyr Pharma, Inc.

vs TVGN

Market Cap

$28.10M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NSPR

InspireMD, Inc.

vs TVGN

Market Cap

$25.76M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ITOC

iTonic Holdings Ltd.

vs TVGN

Market Cap

$25.98M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ONMD

OneMedNet Corporation

vs TVGN

Market Cap

$29.05M

Price/FCF Ratio

N/A

TTM Avg

2.82

3Y Avg

2.82

5Y Avg

2.82

ATOS

Atossa Therapeutics, Inc.

vs TVGN

Market Cap

$24.54M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

QUCY

Quantum Cyber N.V.

vs TVGN

Market Cap

$29.48M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CNTX

Context Therapeutics Inc.

vs TVGN

Market Cap

$29.53M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

GRDX

GridAI Technologies Corp.

vs TVGN

Market Cap

$29.63M

Price/FCF Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Tevogen Bio Holdings Inc. (TVGN)	$27.15M	N/A	N/A	N/A	N/A
Seres Therapeutics, Inc. (MCRB)vs ›	$27.79M	N/A	87.13	87.13	45.44
aTyr Pharma, Inc. (ATYR)vs ›	$28.10M	N/A	N/A	N/A	N/A
InspireMD, Inc. (NSPR)vs ›	$25.76M	N/A	N/A	N/A	N/A
iTonic Holdings Ltd. (ITOC)vs ›	$25.98M	N/A	N/A	N/A	N/A
OneMedNet Corporation (ONMD)vs ›	$29.05M	N/A	2.82	2.82	2.82
Atossa Therapeutics, Inc. (ATOS)vs ›	$24.54M	N/A	N/A	N/A	N/A
Quantum Cyber N.V. (QUCY)vs ›	$29.48M	N/A	N/A	N/A	N/A
Context Therapeutics Inc. (CNTX)vs ›	$29.53M	N/A	N/A	N/A	N/A
GridAI Technologies Corp. (GRDX)vs ›	$29.63M	N/A	N/A	N/A	N/A

Free Cash Flow Valuation

P/FCF Ratio

N/A

FCF Yield

N/A

Price/FCF Ratio Formula & Definition

P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Price/FCF Ratio: N/A

TVGN Price/FCF Ratio Metrics

TVGN Competitors' Price/FCF Ratio

Free Cash Flow Valuation

Price/FCF Ratio Formula & Definition

Related Metrics